Theranos gets $100M lifeline, with conditions
December 26, 2017 at 10:14 AM EST
The Newark-based startup was once one of Silicon Valley’s best-funded unicorns, having raised $900 million venture capital at a nearly $10 billion valuation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.